Dynamic Biotechnology & Genome Invesco ETF (PBE)
$59.33
0.73 (1.21%)
PBE Stock Quote Delayed 30 Minutes
Previous Close
$59.33
Market Cap
293.68M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2,600
Day's Range
59.29 - 60.19
52-Week Range
38.08 - 63.40
Dividend & Yield
0.00 (0.00%)
PBE Stock Predictions, Articles, and Dynamic Biotechnology & Genome Invesco ETF News
3 of the Best Biotech ETFs on the Market
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
4 Frightful ETFs of This Year (VXX, TAPR, KWT, BBC)
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
